{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T03:22:49Z","timestamp":1752549769367,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10157-022-02250-9","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T16:02:50Z","timestamp":1659628970000},"page":"1100-1110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Akihiro","family":"Tsuchimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Hiyamuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9235-5615","authenticated-orcid":false,"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Fukuoka Kidney disease Registry (FKR) study corporation","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Fujimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hirakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Mitsuiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiichiro","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Tokumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuko","family":"Katafuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Mizumasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Torisu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nagae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taihei","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Ohnaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"2250_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3222","volume":"370","author":"D Luo","year":"2020","unstructured":"Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, et al. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis. BMJ. 2020;370: m3222. https:\/\/doi.org\/10.1136\/bmj.m3222.","journal-title":"BMJ"},{"issue":"6","key":"2250_CR2","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1161\/01.HYP.0000069699.92349.8C","volume":"41","author":"M Tozawa","year":"2003","unstructured":"Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003;41(6):1341\u20135. https:\/\/doi.org\/10.1161\/01.HYP.0000069699.92349.8C.","journal-title":"Hypertension"},{"issue":"2","key":"2250_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.ki.5002017","volume":"71","author":"K Yamagata","year":"2007","unstructured":"Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159\u201366. https:\/\/doi.org\/10.1038\/sj.ki.5002017.","journal-title":"Kidney Int"},{"issue":"8","key":"2250_CR4","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1093\/ndt\/gfs054","volume":"27","author":"A Kanno","year":"2012","unstructured":"Kanno A, Kikuya M, Ohkubo T, Hashimoto T, Satoh M, Hirose T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant. 2012;27(8):3218\u201323. https:\/\/doi.org\/10.1093\/ndt\/gfs054.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2250_CR5","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ajh\/hpv003","volume":"28","author":"A Hirayama","year":"2015","unstructured":"Hirayama A, Konta T, Kamei K, Suzuki K, Ichikawa K, Fujimoto S, et al. Blood pressure, proteinuria, and renal function decline: associations in a large community-based population. Am J Hypertens. 2015;28(9):1150\u20136. https:\/\/doi.org\/10.1093\/ajh\/hpv003.","journal-title":"Am J Hypertens"},{"issue":"5","key":"2250_CR6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/kisup.2012.46","volume":"2","author":"G Becker","year":"2012","unstructured":"Becker G, Wheeler D, Zeeuw D, Fujita T, Furth S, Holdaas H, et al. Kidney Disease: Improving Global Outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337\u2013414.","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"2250_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.kint.2018.12.025","volume":"95","author":"AK Cheung","year":"2019","unstructured":"Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, et al. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(5):1027\u201336. https:\/\/doi.org\/10.1016\/j.kint.2018.12.025.","journal-title":"Kidney Int"},{"issue":"3","key":"2250_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","volume":"99","author":"AK Cheung","year":"2021","unstructured":"Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):559\u201369. https:\/\/doi.org\/10.1016\/j.kint.2020.10.026.","journal-title":"Kidney Int"},{"issue":"9","key":"2250_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2215\/CJN.00550113","volume":"8","author":"RM Tanner","year":"2013","unstructured":"Tanner RM, Calhoun DA, Bell EK, Bowling CB, Gutierrez OM, Irvin MR, et al. Prevalence of apparent treatment-resistant hypertension among individuals with CKD. Clin J Am Soc Nephrol. 2013;8(9):1583\u201390. https:\/\/doi.org\/10.2215\/CJN.00550113.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2250_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.115.06487","volume":"67","author":"G Thomas","year":"2016","unstructured":"Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, et al. Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: report from the chronic renal insufficiency cohort study. Hypertension. 2016;67(2):387\u201396. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06487.","journal-title":"Hypertension"},{"issue":"3","key":"2250_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10157-016-1294-4","volume":"21","author":"S Tanaka","year":"2017","unstructured":"Tanaka S, Ninomiya T, Fujisaki K, Yoshida H, Nagata M, Masutani K, et al. The Fukuoka Kidney disease Registry (FKR) Study: design and methods. Clin Exp Nephrol. 2017;21(3):465\u201373. https:\/\/doi.org\/10.1007\/s10157-016-1294-4.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2250_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10157-020-01950-4","volume":"25","author":"A Fukui","year":"2021","unstructured":"Fukui A, Nakayama M, Tanaka S, Matsukuma Y, Yoshitomi R, Nakano T, et al. Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study. Clin Exp Nephrol. 2021;25(1):9\u201318. https:\/\/doi.org\/10.1007\/s10157-020-01950-4.","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"2250_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s10157-020-02018-z","volume":"25","author":"M Hara","year":"2021","unstructured":"Hara M, Tanaka S, Torisu K, Matsukuma Y, Tsuchimoto A, Tokumoto M, et al. Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study. Clin Exp Nephrol. 2021;25(8):822\u201334. https:\/\/doi.org\/10.1007\/s10157-020-02018-z.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"2250_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10157-020-02000-9","volume":"25","author":"T Nakano","year":"2021","unstructured":"Nakano T, Tanaka S, Tsuruya K, Kitazono T. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study. Clin Exp Nephrol. 2021;25(4):385\u201393. https:\/\/doi.org\/10.1007\/s10157-020-02000-9.","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"2250_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.034.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2250_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0031-3955(16)36251-4","volume":"34","author":"GJ Schwartz","year":"1987","unstructured":"Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin N Am. 1987;34(3):571\u201390.","journal-title":"Pediatr Clin N Am"},{"issue":"1","key":"2250_CR17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):S1-150.","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"2250_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.jhh.1001307","volume":"16","author":"T Tanaka","year":"2002","unstructured":"Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16(2):97\u2013103. https:\/\/doi.org\/10.1038\/sj.jhh.1001307.","journal-title":"J Hum Hypertens"},{"issue":"10","key":"2250_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1291\/hypres.27.755","volume":"27","author":"T Ohkubo","year":"2004","unstructured":"Ohkubo T, Obara T, Funahashi J, Kikuya M, Asayama K, Metoki H, et al. Control of blood pressure as measured at home and office, and comparison with physicians\u2019 assessment of control among treated hypertensive patients in Japan: first report of the Japan Home versus Office blood pressure Measurement Evaluation (J-HOME) Study. Hypertens Res. 2004;27(10):755\u201363. https:\/\/doi.org\/10.1291\/hypres.27.755.","journal-title":"Hypertens Res"},{"issue":"3","key":"2250_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1291\/hypres.29.143","volume":"29","author":"H Mori","year":"2006","unstructured":"Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res. 2006;29(3):143\u201351. https:\/\/doi.org\/10.1291\/hypres.29.143.","journal-title":"Hypertens Res"},{"issue":"6","key":"2250_CR21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1161\/01.hyp.0000164577.81087.70","volume":"45","author":"CA Peralta","year":"2005","unstructured":"Peralta CA, Hicks LS, Chertow GM, Ayanian JZ, Vittinghoff E, Lin F, et al. Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005;45(6):1119\u201324. https:\/\/doi.org\/10.1161\/01.hyp.0000164577.81087.70.","journal-title":"Hypertension"},{"issue":"3","key":"2250_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","volume":"55","author":"P Muntner","year":"2010","unstructured":"Muntner P, Anderson A, Charleston J, Chen Z, Ford V, Makos G, et al. Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2010;55(3):441\u201351. https:\/\/doi.org\/10.1053\/j.ajkd.2009.09.014.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2250_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrneph.2012.260","volume":"9","author":"PA Sarafidis","year":"2013","unstructured":"Sarafidis PA, Georgianos P, Bakris GL. Resistant hypertension-its identification and epidemiology. Nat Rev Nephrol. 2013;9(1):51\u20138. https:\/\/doi.org\/10.1038\/nrneph.2012.260.","journal-title":"Nat Rev Nephrol"},{"key":"2250_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060732","author":"C Garofalo","year":"2018","unstructured":"Garofalo C, Borrelli S, Provenzano M, De Stefano T, Vita C, Chiodini P, et al. Dietary salt restriction in chronic kidney disease: a meta-analysis of randomized clinical trials. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10060732.","journal-title":"Nutrients"},{"issue":"11","key":"2250_CR25","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1503\/cmaj.121468","volume":"185","author":"J Lv","year":"2013","unstructured":"Lv J, Ehteshami P, Sarnak MJ, Tighiouart H, Jun M, Ninomiya T, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185(11):949\u201357. https:\/\/doi.org\/10.1503\/cmaj.121468.","journal-title":"CMAJ"},{"issue":"22","key":"2250_CR26","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1511939.","journal-title":"N Engl J Med"},{"issue":"11","key":"2250_CR27","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1161\/circulationaha.104.490599","volume":"112","author":"TJ Wang","year":"2005","unstructured":"Wang TJ, Vasan RS. Epidemiology of uncontrolled hypertension in the United States. Circulation. 2005;112(11):1651\u201362. https:\/\/doi.org\/10.1161\/circulationaha.104.490599.","journal-title":"Circulation"},{"issue":"5","key":"2250_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2215\/cjn.04330418","volume":"14","author":"AD Sinha","year":"2019","unstructured":"Sinha AD, Agarwal R. Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD. Clin J Am Soc Nephrol. 2019;14(5):757\u201364. https:\/\/doi.org\/10.2215\/cjn.04330418.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"19","key":"2250_CR29","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris G, Black H, Cushman W, Green L, Izzo J, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201372. https:\/\/doi.org\/10.1001\/jama.289.19.2560.","journal-title":"JAMA"},{"issue":"19","key":"2250_CR30","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","volume":"289","author":"BM Psaty","year":"2003","unstructured":"Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289(19):2534\u201344. https:\/\/doi.org\/10.1001\/jama.289.19.2534.","journal-title":"JAMA"},{"issue":"27","key":"2250_CR31","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","volume":"385","author":"R Agarwal","year":"2021","unstructured":"Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, et al. Chlorthalidone for hypertension in advanced chronic kidney disease. N Engl J Med. 2021;385(27):2507\u201319. https:\/\/doi.org\/10.1056\/NEJMoa2110730.","journal-title":"N Engl J Med"},{"issue":"2","key":"2250_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.hyp.0000174243.39897.6c","volume":"46","author":"G Grassi","year":"2005","unstructured":"Grassi G, Facchini A, Trevano FQ, Dell\u2019Oro R, Arenare F, Tana F, et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005;46(2):321\u20135. https:\/\/doi.org\/10.1161\/01.hyp.0000174243.39897.6c.","journal-title":"Hypertension"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02250-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02250-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T12:19:01Z","timestamp":1666009141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02250-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["2250"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02250-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"2 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Honoraria: Takanari Kitazono (Bayer Pharmaceutical Co., and Daiichi-Sankyo Co.) and Kazuhiko Tsuruya (Mitsubishi Tanabe Pharma Co., Astellas Pharma Inc., Bayer Pharmaceutical Co., Kissei Pharmaceutical Co., Chugai Pharmaceutical Co. and Kyowa Kirin Co.); Donations: Takanari Kitazono (Astellas Pharma Inc., Daiichi-Sankyo Co., Eisai Co., Kyowa Kirin Co., Mitsubishi Tanabe Pharma Co., MSD KK, Ono Pharmaceutical Co., Otsuka Pharmaceutical Co., Sanofi-Aventis Pharmaceutical Co., and Takeda Pharmaceutical Co.) and Kazuhiko Tsuruya (Chugai Pharmaceutical Co., Kyowa Kirin Co., Baxter Co., and Terumo Co.)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee at which the studies were conducted (IRB approval number 469-08) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was registered in the UMIN Clinical Trial Registry (UMIN000007988).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal right and ethical approval"}},{"value":"Written informed consent was obtained from all patients at the start of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}